Huang YX, Xu ZM, Zhao L, Cao Y, Chen Y, Qiu YG, Liu YM, Zhang PY, He JC, Li TC. Long-term outcomes of high-risk percutaneous coronary interventions under extracorporeal membrane oxygenation support: An observational study. World J Clin Cases 2022; 10(16): 5266-5274 [PMID: 35812664 DOI: 10.12998/wjcc.v10.i16.5266]
Corresponding Author of This Article
Tian-Chang Li, MD, PhD, Chief Physician, Department of Cardiology, Sixth Medical Center of Chinese People’s Liberation Army General Hospital, No. 6 Fucheng Road, Beijing 100048, China. itc909@163.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Huang YX, Xu ZM, Zhao L, Cao Y, Chen Y, Qiu YG, Liu YM, Zhang PY, He JC, Li TC. Long-term outcomes of high-risk percutaneous coronary interventions under extracorporeal membrane oxygenation support: An observational study. World J Clin Cases 2022; 10(16): 5266-5274 [PMID: 35812664 DOI: 10.12998/wjcc.v10.i16.5266]
World J Clin Cases. Jun 6, 2022; 10(16): 5266-5274 Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5266
Long-term outcomes of high-risk percutaneous coronary interventions under extracorporeal membrane oxygenation support: An observational study
Yi-Xiong Huang, Zheng-Ming Xu, Li Zhao, Yi Cao, Yu Chen, Yi-Gang Qiu, Ying-Ming Liu, Peng-Yu Zhang, Jiang-Chun He, Tian-Chang Li
Yi-Xiong Huang, Medical School of Chinese People’s Liberation Army, Beijing 100853, China
Yi-Xiong Huang, Zheng-Ming Xu, Li Zhao, Yi Cao, Yu Chen, Yi-Gang Qiu, Ying-Ming Liu, Peng-Yu Zhang, Jiang-Chun He, Tian-Chang Li, Department of Cardiology, Sixth Medical Center of Chinese People’s Liberation Army General Hospital, Beijing 100048, China
Author contributions: Huang YX, Chen Y, and Li TC designed the study; Huang YX drafted the manuscript; Cao Y, Qiu YG, Liu YM, and He JC revised it critically for important intellectual content; Xu ZM, Zhao L, and Zhang PY contributed to the analysis and interpretation of data; Li TC, the corresponding author of this manuscript, gave final approval of the manuscript submitted.
Institutional review board statement: The study was reviewed and approved by the Sixth Medical Center of PLA General Hospital Institutional Review Board (Beijing).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: There are no conflicts of interest to report.
Data sharing statement: Technical appendix, statistical code, and dataset are available from the corresponding author at itc909@163.com.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tian-Chang Li, MD, PhD, Chief Physician, Department of Cardiology, Sixth Medical Center of Chinese People’s Liberation Army General Hospital, No. 6 Fucheng Road, Beijing 100048, China. itc909@163.com
Received: August 2, 2021 Peer-review started: August 2, 2021 First decision: December 17, 2021 Revised: December 30, 2021 Accepted: April 2, 2022 Article in press: April 2, 2022 Published online: June 6, 2022 Processing time: 303 Days and 20 Hours
ARTICLE HIGHLIGHTS
Research background
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) offers hemodynamic support for patients who undergo high-risk percutaneous coronary intervention (PCI). However, long-term outcomes associated with VA-ECMO have not previously been studied.
Research motivation
High-risk PCI can result in hemodynamic instability during the perioperative period and is associated with poor outcomes. Hemodynamic support is crucial in patients undergoing high-risk PCI.
Research objectives
To investigate long-term outcomes in high-risk cases receiving PCI supported by VA-ECMO.
Research methods
Patients who received VA-ECMO-supported high-risk PCI were assessed. High-risk PCI was defined according to the patient’s hemodynamic status, clinical features, underlying diseases, and coronary anatomy/lesion complexities. The long-term outcomes comprising all-cause mortality, repeated cardiovascular diseases, and cardiac death were recorded.
Research results
Of 61 enrolled patients, 57 patients (93.4%) were successfully treated by VA-ECMO-supported PCI. The in-hospital mortality was 23.0%, and the overall survival was 45.9% with a median follow-up period of 38.6 (8.6-62.1) mo.
Research conclusions
VA-ECMO can be used as a support for patients undergoing high-risk PCI as it is related to favorable long-term patient survival.
Research perspectives
A large multicenter prospective trial is required to confirm the benefit and safety of VA-ECMO-supported high-risk PCI.